Learning Objectives:

  1. Discuss current treatment outcomes in advanced-phase MPNs
  2. Review incidence of IDH mutations in pH-negative advanced-phase MPNs
  3. Discuss potential treatment strategies in IDH-mutated advanced-phase MPNs

and

  1. Review the unique challenges in the care of the AYA patient with cancer
  2. Discuss the spectrum of symptoms experienced by AYA patients and identify gaps in the literature
  3. Describe a study to determine the impact of early palliative care involvement on AYA patients with hematologic malignancies
Session date: 
Monday, November 4, 2019 - 12:00pm to 1:00pm
Speaker Name: 
Anand A. Patel, MD and Amy Y. Wang, MD, PhD
Location: 
UCMC
900 East 57th Street
KCBD Auditorium 1103
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.